WS08.6 Impact of triple therapy on IVantibiotic requirements in cystic fibrosis: combining evidence from a patient Registry and randomised trials

Ruth H. Keogh, Rebecca Cosgriff, Eleni‐Rosalina Andrinopoulou, K. Brownlee, S.b. Carr, Karla Díaz-Ordaz, Emily Granger, Nicholas P. Jewell, Alex Lewin, Clémence Leyrat, Daniela K Schlüter, Maarten van Smeden, Rhonda D. Szczesniak, Gary ConnettJournal of Cystic Fibrosis 2021 · DOI

BibTeX
@article{keogh2021ws,
  author = {Ruth H. Keogh and Rebecca Cosgriff and Eleni‐Rosalina Andrinopoulou and K. Brownlee and S.B. Carr and Karla Díaz-Ordaz and Emily Granger and Nicholas P. Jewell and Alex Lewin and Clémence Leyrat and Daniela K Schlüter and Maarten van Smeden and Rhonda D. Szczesniak and Gary Connett},
  title = {{WS08.6 Impact of triple therapy on IVantibiotic requirements in cystic fibrosis: combining evidence from a patient Registry and randomised trials}},
  journal = {Journal of Cystic Fibrosis},
  year = {2021},
  doi = {10.1016/s1569-1993(21)00962-0},
}

Loading related content...

Figure